abrdn World Healthcare Fund THW Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Aug 14, 2024 (filed on Aug 16, 2024)

Insider Name:

Maher Bill

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,000

Price:

$13.03
Jul 16, 2024 (filed on Jul 18, 2024)

Insider Name:

DiMartino Rose

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,000

Price:

$13.31
Jun 18, 2024 (filed on Jun 18, 2024)

Insider Name:

Nichols Rebecca Suzanne

Ownership Type:

Direct Ownership

Securities:

Common Shares

Nature of Transaction:

Form 3 : Initial Statement of Beneficial Ownership of Securities

# or value acquired/disposed of:

--

Price:

--
Apr 09, 2024 (filed on Apr 12, 2024)

Insider Name:

Goetz Kathleen

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

200

Price:

$12.53

Filings by filing date

Aug 14, 2024 (filed on Aug 16, 2024)

Insider Name:

Maher Bill

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,000

Price:

$13.03
Jul 16, 2024 (filed on Jul 18, 2024)

Insider Name:

DiMartino Rose

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

1,000

Price:

$13.31
Jun 18, 2024 (filed on Jun 18, 2024)

Insider Name:

Nichols Rebecca Suzanne

Ownership Type:

Direct Ownership

Securities:

Common Shares

Nature of Transaction:

Form 3 : Initial Statement of Beneficial Ownership of Securities

# or value acquired/disposed of:

--

Price:

--
Apr 09, 2024 (filed on Apr 12, 2024)

Insider Name:

Goetz Kathleen

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

200

Price:

$12.53

News

Biz Brief

Sector: Financials	Industry: Closed End Funds

See Regulatory Filings on SEC

Company Contact

Address:	1900 Market Street, Suite 200 PHILADELPHIA PA 19103
Tel:	N/A
Website:	https://www.abrdnthw.com
IR:	See website

Key People

Daniel R. Omstead President, Trustee	Laura Woodward Chief Compliance Officer, Treasurer, Secretary

Business Overview

abrdn World Healthcare Fund (the Fund), formerly Tekla World Healthcare Fund, is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation. The Fund invests primarily in equity and debt securities of public and private United States and non-United States companies. The Fund is focused on investing at least 40% of its managed assets in companies organized or located outside the United States or companies that do a substantial amount of business outside the United States. The Fund may invest up to 20% of managed assets, measured at the time of investment, in non-convertible debt of healthcare companies. The Fund may also invest up to 20% of managed assets in healthcare real estate investment trusts. The Fund invests in sectors, which include biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, healthcare distributors, and others. The Fund's investment adviser is abrdn Inc.

Financial Overview

For the fiscal year ended 30 September 2024, abrdn World Healthcare Fund revenues decreased 1% to $12.7M. Net income increased from $37.6M to $93.4M. Revenues reflect Dividend income decrease of 19% to $8.3M. Net income reflects Unrealized G/L on Investment Securities increase from $5.6M to $91.3M (income), Forward contracts increase from $3.3M (expense) to $22K (income), Milestone interests increase from $139K (expense) to $198K (income).

Reporting Currency:	U.S. Dollars
Enterprise value:	N/A
Annual revenue (TTM):	$12.67M as of Sep 30, 2024
EBITDA (TTM):	-$2.30M as of Sep 30, 2024
Net annual income (TTM):	$93.36M as of Sep 30, 2024
Free cash flow (TTM):	N/A
Net Debt Last Fiscal Year:	$120.00M as of Sep 30, 2024
Shares outstanding:	38,453,463 as of Sep 30, 2024
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization